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httpicense.Abstract Fibromyalgia (FM) is a diffuse, chronic pain syndrome associated with tender body
areas and somatic complaints. A high prevalence of undetected carpal tunnel syndrome (CTS) in
patients with FM has been reported and it seems to affect their functional level.
The aim of the work: This study was designed to compare between the presence of CTS in FM
patients and control subjects and to ﬁnd out if the severity of CTS is correlated with the functional
impairment questionnaire (FIQ) score.
Patients & methods: The study was carried out on 100 females, divided into two groups: 40
patients with ﬁbromyalgia, their ages ranged from 20 to 45 years and 60 healthy controls, their ages
ranged from 20 to 42 years. All subjects were subjected to full history taking, full locomotor exam-
ination, calculation of body mass index (BMI) and electrodiagnosis for CTS. Patients were asked to
complete the FIQ.
Results: FM patients had a signiﬁcantly higher frequency of CTS as compared to the control
group. Moderate CTS was more frequent among the patients. There was a highly statistically sig-
niﬁcant correlation between the severity of CTS and the FIQ score. Also there was a highly statis-
tically signiﬁcant difference as regards the FIQ score between the two subgroups of patients.
Conclusion: CTS is more frequent in patients with FM than the normal population. Correlations
between the severity of CTS and the FIQ score prove that CTS is one of the main causes of impair-
ment in patients with FM.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis. Open access under CC BY-NC-ND license.4704146.
com (A.M. El-Shafey).
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Fibromyalgia (FM) is a syndrome of unknown etiology, char-
acterized by chronic widespread pain, and increased tenderness
on palpation. Some other disorders like irritable bowel syn-
drome, disrupted sleep, stiffness, fatigue, psychological disease
and cold intolerance, migraine and premenstrual syndrome are
also related to this speciﬁc syndrome [1]. The symptoms re-
ported by ﬁbromyalgia patients often contrast sharply withgyptian Society for Joint Diseases and Arthritis.
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rological examinations and with normal laboratory and radio-
graphic tests. Fibromyalgia patients are typically affected with
substantial disability and emotional distress [2].
Fibromyalgia has an estimated prevalence of 2% of the
United States adult general population and its prevalence in-
creases in women, peaking between ages 54 and 64 years and
then decreasing. The prevalence in men is fairly constant
across ages [3]. Parasthesia and sensory alterations are prob-
lematic complaints seen in >80% of FM patients. They may
be confused with entrapment neuropathies and radiculopa-
thies. The mechanism of parasthesia in FM is not exactly
known. However, parasthesia is considered to be a result of
an abnormal sensory perception occurring due to central sen-
sitization [4]. However, peripheral mechanisms in muscles and
nerves have not been excluded as possible sources of pain and
parasthesia in ﬁbromyalgia [5].
Carpal tunnel syndrome (CTS) is a clinical syndrome of
numbness, tingling, burning, and/or pain associated with local-
ized compression of the median nerve at the wrist. It is the
most commonly reported nerve compression syndrome [6].
Parasthesia and pain in the hands, increasing especially at
night, and morning stiffness can be seen in FM as is also seen
in CTS. The similarity between the symptoms both in FM and
CTS and the incidence of both entities in women may lead to
confusion and thus may make one disease mask the other [7].
A high prevalence of undetected CTS in patients with FM
has been reported [8]. Additionally, a possible association be-
tween FM and CTS was suggested because of the higher prev-
alence of CTS in FM than in the normal population [9,10].
It seems that patients with ﬁbromyalgia experience a lower
quality of life as compared to the general population. Many
patients provided a broad range of areas on which FM had
a signiﬁcant and negative impact on their lives including their
mood, family and social relationships, and work productivity.
Some of them stated that their disease affects every aspect of
their life. Patients also discussed the need to push themselves
to do activities and indicated that the fatigue they experience
makes even simple tasks, such as taking a shower, difﬁcult [11].
This study was designed to compare between the presence
of CTS in patients with FM and normal control subjects and
to ﬁnd out if the severity of CTS is correlated with the ﬁbromy-
algia impairment questionnaire (FIQ) score in FM patients.2. Patients and methods
2.1. Selection of patients
The study included 40 patients diagnosed with Fibromyalgia
syndrome according to the American College of Rheumatology
(ACR) criteria [12], selected from those attending the Rheuma-
tology &Rehabilitation outpatient clinics & inpatients’ Depart-
ment in the Zagazig University Hospitals. All the patients were
females, their ages ranged from 20 to 45 years.
Sixty apparently healthy females served as a control group
for the nerve conduction study.
Patients with other rheumatological, neurological and vas-
cular diseases and those with endocrinal or metabolic diseases
were excluded from the study. Patients with previous distal
radius fracture and those with a history of medication use lead-
ing to neuropathy were also excluded. To avoid the risk factorof the patient job, all subjects involved in this work were
housewives, of moderate socio-economic standard. None of
the patients or controls performed repetitive wrist activities.
The study was approved by the local Ethics Committee of
the university. The study was explained to the participants
and an informed consent was given by each one.
2.2. History & clinical examination
Every patient was subjected to the following
1- Detailed history taking (demographic data, history of
present condition, past history, family history and men-
strual history).
2- General examination with stress on musculoskeletal
examination (including tender points), Phallen and Tin-
nel test and complete neurological examination. Body
mass index (BMI) was calculated for each patient.
2.3. Assessment of functional status of FM patients
Fibromyalgia impact questionnaire (FIQ) [13] was completed
by every patient.
The FIQ is an assessment and evaluation instrument devel-
oped to measure FM patient status, progress and outcomes. It
has been designed to measure the components of health status
that are believed to be most affected by FM [13].
The FIQ is composed of 10 items. The ﬁrst item contains 11
questions (‘‘a’’ through ‘‘k’’) related to physical functioning –
each question is rated on a 4 point Likert type scale. Items 2
and 3 ask the patient to mark the number of days they felt well
and the number of days they were unable to work (including
housework) because of ﬁbromyalgia symptoms. Items 4
through 10 are horizontal lines, 10 cm in length, in which the
patient rates work difﬁculty, pain, fatigue, morning tiredness,
stiffness, anxiety and depression.
2.4. Electrodiagnosis
Electrodiagnosis of the upper limb was performed at room
temperature with a Viking Quest Nicolet electromyography
equipment. Conduction studies of the median and ulnar nerves
and median nerve F-wave latencies were assessed in both
upper extremities using standard methods [14].
Motor conduction studies were performed using an ortho-
dromic method and superﬁcial disc electrodes. Electrodes were
placed over the abductor pollicis brevis muscle for the median
nerve and the adductor digiti minimi muscle for the ulnar
nerve. The active recording electrode was placed on the belly
of the examined muscle and the reference electrode was placed
on the tendon insertion. Compound muscle action potential
(CMAP) was obtained by stimulating the median nerve at
the wrist (5 cm proximal to the active recording electrode
placed on the abductor pollicis brevis muscle) and antecubital
fossa and the ulnar nerve at the wrist (5 cm proximal to the ac-
tive recording electrode placed on the adductor digiti minimi
muscle) and at the ulnar sulcus. Motor distal latency (DL)
was measured from the beginning of the stimulus artifact to
the onset of the action potential. Peak-to-peak CMAP ampli-
tude was measured.
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dromic method and ring electrodes. Digit2-wrist segment was
used for median sensory nerve conduction studies and digit5-
wrist segment was used for ulnar sensory nerve conduction
studies. Sensory NCVs were calculated from the beginning of
the stimulus artifact to the onset of the sensory nerve action
potential (SNAP). Peak-to-peak amplitudes were measured.
F-wave study was performed for the median nerve by
recording from the same muscle using the electrode placement
mentioned above. Active stimulating electrode was placed
proximally and at least 10 successive supramaximal stimula-
tions were given. Minimum F-wave latency (F min) was re-
corded. CTS was diagnosed electrophysiologically if the
median nerve sensory NCV was decreased and/or motor DL
was prolonged.
Motor nerve conduction velocities below 50 m/s were con-
sidered abnormal [15]. Sensory nerve conduction velocities
were considered abnormal if below 56.9 ± 4 m/s for median
nerve or below 57 ± 5 m/s for ulnar nerve. Peak latencies of
SNAPs of both median and ulnar nerves more than 3.2 ms
were considered prolonged. F wave latencies above
29.1 ± 2.3 for the median nerve or above 30.5 ± 3 for the ul-
nar nerve were considered prolonged [16].
According to the criteria of Padua et al., 1997 the severity
of CTS was evaluated as negative (normal ﬁndings), minimal
or very mild (abnormal sensory nerve conduction study of
the palm–wrist segment), mild (abnormal sensory nerve con-
duction study of any of the ﬁnger–wrist (digits I–III) segments
and normal motor DL), moderate (abnormal sensory nerve
conduction study of any of the ﬁnger–wrist (digits I–III) seg-
ments and prolonged motor DL), severe (absence of the com-
pound nerve action potential of any ﬁnger–wrist segment and
prolonged motor DL), extreme (absence of compound nerve
action potential of any ﬁnger–wrist segment and CMAP) CTSs
[17].
The palm wrist segment SNCV was calculated by subtract-
ing the SNCV of third digit to the palm from the SNCV of
third digit to the wrist [15].
Statistical analysis: Data were analyzed using SPSS soft-
ware package version 18.0 (SPSS, Chicago, IL, USA). Quanti-
tative data were expressed using range, mean, standard
deviation and median, while qualitative data were expressed
in frequency and percent. Quantitative data were analyzed
using Student’s t-test to compare between the two groups.
Pearson coefﬁcient was used to analyze the correlation be-
tween any two quantitative variables. p Value was assumed
to be signiﬁcant at 0.05 or less.Table 1 Comparison between ﬁbromyalgia patients (FM) and the
FM (Total No. = 40)
Age range (Min–Max) 20–45
Mean ± SD 31.75 ± 6.31
BMI range (Min–Max) 21–39
Mean ± SD 28.02 ± 5.3
BMI: body mass index.
*Signiﬁcance at P< 0.05.
**High signiﬁcance at P< 0.001.3. Results
3.1. Demographic data
This study was carried out on 100 female housewives: 40 pa-
tients suffering from ﬁbromyalgia and 60 healthy female vol-
unteers were taken as control group. There were non-
signiﬁcant differences between both groups as regards their
age and BMI (Table 1).
3.2. Prevalence of CTS in FM patients
In our study, 22 (55%) of FM patients and none of control
subjects were suffering from parasthesia. By clinical examina-
tion, only 11 FM patients and 4 of control subjects had po-
sitive signs for CTS, in the form of positive Phalen’s test or
Tinnel’s sign.
By electrophysiological studies, the prevalence of CTS in
FM patients in our study was 42.5% (n= 17), while it was
10% (n= 6) in the control subjects (Table 2). This means that
6 FM patients and 2 control subjects had subclinical CTS,
diagnosed electrophysiologically.
We compared the presence of CTS between patients and
control subjects. FM patients had a signiﬁcantly higher fre-
quency of CTS as compared to the control group
(p< 0.001). Moderate CTS was more frequent among the pa-
tients (p< 0.001) while there were no statistically signiﬁcant
differences in the frequencies of minimal, mild and severe
CTS between both groups.
3.3. Correlation between the severity of CTS and age, BMI and
disease presentation of FM patients
In our study, there was a highly statistically signiﬁcant corre-
lation between the severity of CTS and both BMI and FIQ
score of FM patients (Table 3).
3.4. Higher FIQ score in FM patients with CTS
Patients with CTS had their FIQ scores ranging from 28 to 79,
with a mean ± SD equal to 59.41 ± 14.4. While patients with-
out CTS had their FIQ scores ranging from 24 to 52, with a
mean ± SD equal to 37.5 ± 7.4. We found the difference
highly statistically signiﬁcant as regards the FIQ score between
the two subgroups (p< 0.001).control as regards their age & body mass index.
Control (total No. = 60) t Test P value
20–42 1.59 0.115
29.8 ± 5.8
21–35 1.74 0.085
26.3 ± 4.3
Table 2 Comparison between FM patients and the control as
regards the occurrences and the degree of CTS.
Degree of
CTS No. (%)
FM
(Total No. = 40)
Control
(Total No. = 60)
P value
Minimal 2 (5%) 3 (5%) 1.0 a
Mild 6 (15%) 3 (5%) 0.08 a
Moderate 8 (20%) 0 (0%) –
Severe 1 (2.5%) 0 (0%) –
Extreme 0 (0%) 0 (0%) NA
No. of CTS 17 (42.5%) 6 (10%) **<0.001a
a: X2 Chi-square test.
b: Fisher exact test.
NA= statistical test cannot be calculated.
*Signiﬁcance at P< 0.05.
** High signiﬁcance at P< 0.001.
Table 3 Correlation between the degree of CTS and clinical
parameters of FM patients.
R P value
Age (years) 0.074 0.649
BMI 0.599 <0.001**
Disease duration (years) 0.029 0.858
No. of tender points 0.039 0.812
FIQ 0.815 <0.001**
R: Pearson correlation.
BMI: body mass index.
FIQ: ﬁbromyalgia impact questionnaire.
*Signiﬁcance at P< 0.05.
** High signiﬁcance at P< 0.001.
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Fibromyalgia can have a substantial impact on patients’ lives.
A survey of women utilizing the National Fibromyalgia Asso-
ciation Web site reported substantial disability with ﬁbromyal-
gia [18]. A high prevalence of undetected carpal tunnel
syndrome CTS in patients with FM has been reported [8].
This study was designed to compare between the presence
of CTS in FM patients and normal control subjects and to dis-
cover if it could be a cause of disability in FM patients.
In our study, the prevalence of CTS in FM patients was
42.5%, while it was 10% in the control subjects. This differ-
ence was highly statistically signiﬁcant (p< 0.001). This is
much higher than the prevalence reported by Sarmer and col-
leagues which was 10% in FM patients and 4% in control sub-
jects, and the difference did not reach statistically signiﬁcant
levels [19]. We refer to this difference by that we assessed the
presence of minimal CTS, deﬁned by delay of sensory conduc-
tion velocity in the palm-wrist segment, which was not assessed
in their study.
Also, Tosun and colleagues found the prevalence of CTS
was higher than control subjects, although it did not reach sta-
tistically signiﬁcant levels [7]. In older studies, the prevalence
of CTS in FM patients was reported as 16% [8] and 9.7%
[9]. The latter did not perform electrophysiological examina-
tions in their study but the diagnosis relied only on anamnesis
and provocative tests. In a recent study, CTS was electrophys-iologically detected in 25.39% of FM patients, and in 3.84% of
the healthy control group. They suggested that CTS is ob-
served more frequently in the patients with FM [20].
Patient’s occupation could be a causative agent for the pres-
ence of CTS. To avoid the effect of occupation, all subjects in-
volved in this work were housewives, of moderate socio-
economic standard.
We suppose that the higher prevalence in our patients is due
to the detailed electrophysiological tests and the higher num-
ber of control subjects than that of patients. We performed ul-
nar nerve conduction studies and F waves in order to exclude
peripheral neuropathies and root affection.
In our patients, there was a statistically signiﬁcant correla-
tion between the severity of CTS and patients’ BMI. It has
been reported that compression neuropathies are frequently
observed ﬁndings in patients with FM [21]. This ﬁnding may
be connected with weight gain, musculoskeletal pain, biome-
chanical factors secondary to hypermobility and increased sen-
sitization appearing as a result of central sensitization [22,4].
In 2003, Ersoz found that 15% of FM patients had median
mononeuropathy at the wrist, while in the control group; only
5.9% had median mononeuropathy at the wrist. They reported
that, focal neuropathies in FM patients are common. The eti-
ology of such entrapments is most likely multifactorial. Simple
nerve compression secondary to weight loss, prolonged periods
of immobilization, incorrect positioning of body parts and
repetitive motion are likely to be important [23].
Ferry and colleagues have suggested that the increased inci-
dence of CTS in women may be partly due to hormonal factors
but is also related to an underlying propensity to musculoskel-
etal problems and their higher overall frequency in women. As
FM is one of the common musculoskeletal problems in fe-
males, the increased CTS prevalence in women may be due
to coexisting FM [24].
Actually, this point was not deﬁnite in our study, as the cor-
relations between the severity of CTS and both the disease
duration and the number of tender points did not reach signif-
icant levels.
A study in the beginning of this century suggested common
mechanisms in the pathogenesis of FM and CTS. They recom-
mended that tenosynovitis at the wrist for FM patients needs
to be investigated by ultrasonography or magnetic resonance
imaging in further studies [19].
In our study, there was a highly statistically signiﬁcant cor-
relation between the severity of CTS and both BMI and FIQ
scores of FM patients (p< 0.001). Moreover, comparison be-
tween FM patients with and without CTS as regards their level
of impairment, presented by the FIQ score, revealed highly sta-
tistically signiﬁcant difference, with a higher mean value in FM
patients with CTS (p< 0.001).
The FIQ is an assessment and evaluation instrument devel-
oped to measure FM patient’s functional status, progress and
outcomes. It has been designed to measure the components of
health status that are believed to be most affected by FM [13].
To our knowledge, this is the ﬁrst study to compare be-
tween FM patients with and without CTS as regards their level
of impairment.
The correlation between the severity of CTS and the FIQ
score of FM patients and the presence of higher FIQ score
in patients with CTS emphasizes the fact that CTS is a crucial
cause of impairment in FM patients, whether it is or is not a
part of the disease.
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presence of CTS may be masked by the symptoms of FM. This
is conﬁrmed by history and clinical examination of our pa-
tients, as 22 patients were suffering from parasthesia and elec-
trophysiological evidence of CTS was present only in 17
patients. So, patients with FM should be assessed by appropri-
ate electrophysiological tests. Appropriate and effective thera-
peutic interventions for CTS should be applied to improve
quality of life of patients with FM [20].
From another point of view, an old study reported the pres-
ence of FM in patients with CTS as a factor causing the failure
of endoscopic carpal tunnel release operation [25]. Moreover,
Akkus and colleagues emphasized that FM accompaniment
in patients nonresponsive to local steroid injection for CTS
should be kept in mind. They have shown that CTS patients
with FM had less improvement in Boston Questionnaire symp-
tom severity scores than patients with CTS alone. They also
found that bilateral involvement was more common in CTS
patients with FM (38.4%) than in the other group (16.6%)
[26].
Another study proved that the rate of undiagnosed CTS in
women with FM is much higher than that reported in the gen-
eral population. Besides, an undiagnosed FM in patients with
CTS may be possible. The rate of FM was 35.1% in their fe-
male CTS patients [24].
From the previous discussion we conclude that CTS is more
frequent in patients with FM than the normal population.
Electrophysiological examination should be performed for
every patient. Correlations between the severity of CTS and
the FIQ score prove that CTS is one of the main causes of
impairment in patients with FM. So, management of CTS in
these patients should minimize impairments.Conﬂict of interest
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